جوادی, مطهره
دانشگاه علوم پزشکی کرمانشاه، کرمانشاه، ایران
[ 1 ] - بررسی تاثیر داروی فینگولیمود بر تعداد پلاک های مغز بیماران مالتیپل اسکلروز قبل و پس از درمان در تصویربرداری تشدید میدان مغناطیسی
Background: Several treatments have been proposed to control Multiple Sclerosis (MS). Fingolimod is the first oral medication for the disease that was approval by Food and Drug Administration American (FDA) since 2010 and is produced in Iran from October 2013. The aim of this study was evaluation of the effect of fingolimod on the number of brain plaque in multiple sclerosis patients before and...
نویسندگان همکار